These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35814823)

  • 21. Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms.
    Bilotta MT; Abruzzese MP; Molfetta R; Scarno G; Fionda C; Zingoni A; Soriani A; Garofalo T; Petrucci MT; Ricciardi MR; Paolini R; Santoni A; Cippitelli M
    FASEB J; 2019 Aug; 33(8):9489-9504. PubMed ID: 31125275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression profiles of Natural Killer Group 2D Ligands (NGK2DLs) in colorectal carcinoma and changes in response to chemotherapeutic agents.
    Kucuk B; Yilmaz E; Cacan E
    Mol Biol Rep; 2021 May; 48(5):3999-4008. PubMed ID: 34009568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity.
    Yamanegi K; Yamane J; Kobayashi K; Kato-Kogoe N; Ohyama H; Nakasho K; Yamada N; Hata M; Nishioka T; Fukunaga S; Futani H; Okamura H; Terada N
    Oncol Rep; 2010 Dec; 24(6):1621-7. PubMed ID: 21042760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells.
    Ding H; Buzzard GW; Huang S; Sehorn MG; Marcus RK; Wei Y
    PLoS One; 2021; 16(6):e0252662. PubMed ID: 34077462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-Derived Soluble MICA Obstructs the NKG2D Pathway to Restrain NK Cytotoxicity.
    Luo Q; Luo W; Zhu Q; Huang H; Peng H; Liu R; Xie M; Li S; Li M; Hu X; Zou Y
    Aging Dis; 2020 Feb; 11(1):118-128. PubMed ID: 32010486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
    Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
    Sun R; Li AL; Wei HM; Tian ZG
    Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.
    Arreygue-Garcia NA; Daneri-Navarro A; del Toro-Arreola A; Cid-Arregui A; Gonzalez-Ramella O; Jave-Suarez LF; Aguilar-Lemarroy A; Troyo-Sanroman R; Bravo-Cuellar A; Delgado-Rizo V; Garcia-Iglesias T; Hernandez-Flores G; Del Toro-Arreola S
    BMC Cancer; 2008 Jan; 8():16. PubMed ID: 18208618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
    Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J
    J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma.
    Mantovani S; Varchetta S; Mele D; Donadon M; Torzilli G; Soldani C; Franceschini B; Porta C; Chiellino S; Pedrazzoli P; Santambrogio R; Barabino M; Cigala C; Piccolo G; Opocher E; Maestri M; Sangiovanni A; Bernuzzi S; Lhospice F; Kraiem M; Mondelli MU; Oliviero B
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17.
    Ren J; Nie Y; Lv M; Shen S; Tang R; Xu Y; Hou Y; Zhao S; Wang T
    Cell Mol Immunol; 2015 Nov; 12(6):768-76. PubMed ID: 25363527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.
    Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N
    Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.
    Schilling D; Kühnel A; Tetzlaff F; Konrad S; Multhoff G
    Cancer Immunol Immunother; 2015 May; 64(5):599-608. PubMed ID: 25854583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
    Carbone E; Neri P; Mesuraca M; Fulciniti MT; Otsuki T; Pende D; Groh V; Spies T; Pollio G; Cosman D; Catalano L; Tassone P; Rotoli B; Venuta S
    Blood; 2005 Jan; 105(1):251-8. PubMed ID: 15328155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity.
    Min D; Lv XB; Wang X; Zhang B; Meng W; Yu F; Hu H
    Br J Cancer; 2013 Aug; 109(3):723-30. PubMed ID: 23820258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The negative regulatory effect of IFN-gamma on cognitive function of human natural killer cells].
    Zhang C; Tian ZG; Zhang J; Feng JB; Zhang JH; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):324-7. PubMed ID: 15312339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation Roles of MICA and NKG2D in Human Renal Cancer Cells.
    Jia HY; Liu JL; Yuan MZ; Zhou CJ; Sun WD; Zhao JJ; Wang J; Liu L; Luan Y
    Asian Pac J Cancer Prev; 2015; 16(9):3901-5. PubMed ID: 25987057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner.
    Du C; Bevers J; Cook R; Lombana TN; Rajasekaran K; Matsumoto M; Spiess C; Kim JM; Ye Z
    J Immunother Cancer; 2019 Aug; 7(1):207. PubMed ID: 31387641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.